Related Experiment Videos
Pharmacodynamics and tolerance of oral sustained release ritodrine
F R Witter1, T J Benedetti, B G Petty
1Johns Hopkins University School of Medicine, Department of Gynecology and Obstetrics, Baltimore, MD 21205.
American Journal of Obstetrics and Gynecology
|September 1, 1988
Abstract:
A new oral sustained release formulation of ritodrine was tested for patient tolerance in this open study. The doses tested were 120 mg/day, 240 mg/day, and 360 mg/day. No objective toxicity was seen at any level. Doses of 120 mg/day and 240 mg/day were well-tolerated. Of the subjects who received the 360 mg/day dose, most tolerated it well.